EPM2A is depressed in most human lymphomas and acts as a tumor suppressor in immunocompromised hosts by dephosphorylating the essential component of the Wnt signaling pathway, GSK-3β (Wang et al., 2006). Here, EPM2A is linked to neoplasm.